Varex Imaging Corp.

How big is Varex Imaging Corp.?

As of Jun 18, Varex Imaging Corp. has a market capitalization of 322.45 million and reported net sales of 827.50 million with a net profit of -41.40 million over the last four quarters. As of Sep 24, shareholder's funds are 535.10 million, and total assets are 1,217.00 million.

As of Jun 18, Varex Imaging Corp. has a market capitalization of 322.45 million, categorizing it as a Micro Cap company.<BR><BR>As of Jun 18, the sum of net sales for the latest four quarters is 827.50 million, while the sum of net profit for the same period is -41.40 million.<BR><BR>As of Sep 24, the shareholder's funds are reported at 535.10 million, and the total assets amount to 1,217.00 million.

What does Varex Imaging Corp. do?

Varex Imaging Corporation supplies medical X-ray tubes and image processing solutions, operating as a micro-cap company with a market cap of $322.45 million. As of March 2025, it reported net sales of $213 million and a net profit of $7 million.

Overview:<BR>Varex Imaging Corporation is a supplier of medical X-ray tubes and image processing solutions, operating within the Pharmaceuticals & Biotechnology industry and classified as a micro-cap company.<BR><BR>Financial Snapshot:<BR>- Most recent Net Sales: 213 Million (Quarterly Results - Mar 2025)<BR>- Most recent Net Profit: 7 Million (Quarterly Results - Mar 2025)<BR>- Market-cap: USD 322.45 Million (Micro Cap)<BR><BR>Key Metrics:<BR>- Debt Equity: 0.63<BR>- Return on Equity: -7.66%<BR>- Price to Book: 0.59<BR><BR>Contact Details:<BR>- Address: 1678 S Pioneer Rd, SALT LAKE CITY UT: 84104-4205<BR>- Tel: 1 801 9725000, 1 801 9785274<BR>- Fax: 1 302 6365454<BR>- Website: https://www.vareximaging.com/

Should I buy, sell or hold Varex Imaging Corp.?

Who are in the management team of Varex Imaging Corp.?

As of March 2022, Varex Imaging Corp.'s management team includes Dr. Ruediger Naumann-Etienne as Independent Chairman and Mr. Sunny Sanyal as President and CEO, along with independent directors such as Dr. Jocelyn Chertoff and Mr. Timothy Guertin.

As of March 2022, the management team of Varex Imaging Corp. includes the following individuals:<BR><BR>- Dr. Ruediger Naumann-Etienne, Independent Chairman of the Board<BR>- Mr. Sunny Sanyal, President, Chief Executive Officer, and Director<BR><BR>Additionally, the Board of Directors features several independent directors: Dr. Jocelyn Chertoff, Mr. Timothy Guertin, Mr. Jay Kunkel, Mr. Walter Rosebrough, and Ms. Christine Tsingos.

Is Varex Imaging Corp. overvalued or undervalued?

As of November 19, 2024, Varex Imaging Corp. is considered overvalued and risky, with concerning financial metrics including a negative P/E ratio of -12.47 and a negative ROE of -7.66%, indicating struggles in generating returns compared to its peers and the S&P 500.

As of 19 November 2024, Varex Imaging Corp. has moved from a fair to a risky valuation grade. The company appears to be overvalued, particularly given its key ratios: a Price to Book Value of 0.64, an EV to EBITDA of 8.64, and an EV to Sales of 0.84. In comparison to its peers, Varex Imaging Corp. has a P/E ratio of -12.47, while Avanos Medical, Inc. has a P/E of 9.80, indicating a stark difference in valuation metrics.<BR><BR>The company's financial performance is concerning, with a negative ROE of -7.66% and a modest ROCE of 5.96%. This suggests that Varex is struggling to generate returns on equity, which could further justify its risky valuation status. Although specific return data is not available, the lack of positive returns relative to the S&P 500 reinforces the notion that the stock may not be a favorable investment at this time.

Is Varex Imaging Corp. technically bullish or bearish?

As of October 3, 2025, Varex Imaging Corp. shows a mildly bullish trend with positive momentum from MACD indicators, but mixed signals from the RSI and underperformance compared to the S&P 500, including a year-to-date return of -18.71%.

As of 3 October 2025, the technical trend for Varex Imaging Corp. has changed from sideways to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish, indicating positive momentum. However, the weekly RSI is bearish, suggesting some weakness in the short term. The daily moving averages are bullish, supporting the overall positive trend. <BR><BR>In terms of returns, Varex has underperformed the S&P 500 across multiple periods, with a year-to-date return of -18.71% compared to the S&P's 14.18%, and a 3-year return of -46.07% versus the S&P's 82.57%. Overall, the current technical stance is mildly bullish, but the strength is tempered by mixed signals from the RSI and Bollinger Bands.